Matthew L. Kaplan

NVCT

Matthew L. Kaplan serves as Director at Nuvectis Pharma, Inc. (NVCT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$114.9K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$114.9K

Companies Traded

NVCT

Active Period

May 2022 – Nov 2025

2 total trades

Most Recent

Buy NVCT

Nov 5, 2025 · $64.2K

Matthew L. Kaplan's Insider Trading at Nuvectis Pharma, Inc. (NVCT)

Buys

2 · $114.9K

Sells

0 · $0.00

Total Shares Bought

14,000

Total Shares Sold

NVCT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 5, 2025↗	Buy	11,000	$5.84	$64.2K	0
May 16, 2022↗	Buy	3,000	$16.88	$50.6K	35,760

Related Insiders

BENTSUR RON

Chairman & CEO

NVCTBuy · Nov 5, 2025

Juan Sanchez

Director

NVCTBuy · Nov 5, 2025

Marlio Charles Mosseri

10% Owner

NVCTBuy · Oct 23, 2025

Explore More Insider Trading Data

NVCT Insider Trading Activity

View all insider trades at Nuvectis Pharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity